Vascular risk factor awareness before and pharmacological treatment before and after stroke and TIA

European Journal of Neurology

Volumn 16, Issue 6, 2009, Pages 678-683

  Nolte, C H ^a   Jungehulsing, G J ^a   Rossnagel, K ^a   Roll, S ^a   Haeusler, K G ^a   Reich, A ^a   Willich, S N ^a   Villringer, A ^a   Muller Nordhorn, J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adherence; Medical management; Risk factor awareness; Secondary prevention; Stroke

Indexed keywords

ANTICOAGULANT AGENT;

ARTICLE; AWARENESS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT REFUSAL;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; ATRIAL FIBRILLATION; COHORT STUDIES; COMORBIDITY; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; HYPOGLYCEMIC AGENTS; ISCHEMIC ATTACK, TRANSIENT; MALE; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; STROKE;

EID: 65449163423     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02562.x     Document Type: Article

References (34)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997 349 : 1498 1504. (Pubitemid 27216360)
2. Bogousslavsky J, Kaste M, Skyhoj Olsen T, Hacke W, Orgogozo JM. Risk factors and stroke prevention. European Stroke Initiative (EUSI). Cerebrovascular Disease 2000 10 : S12 S21.
3. Leys D, Deplanque D, Mounier-Vehier C, Mackowiak-Cordoliani MA, Lucas C, Bordet R. Stroke prevention: management of modifiable vascular risk factors. Journal of Neurology 2002 249 : 507 517. (Pubitemid 34507822)
4. Weih M, Muller-Nordhorn J, Amberger N, et al. Risk factors in ischemic stroke. Review of evidence in primary prevention. Nervenarzt 2004 75 : 324 335. (Pubitemid 38552501)
5. Sacco RL. Risk factors and outcomes for ischemic stroke. Neurology 1995 45 : S10 S14.
6. Koennecke HC. Secondary prevention of stroke: a practical guide to drug treatment. CNS Drugs 2004 18 : 221 241. (Pubitemid 38393433)
7. Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update. Circulation 2002 106 : 388 391.
8. Samsa GP, Cohen SJ, Goldstein LB, et al. Knowledge of risk among patients at increased risk for stroke. Stroke 1997 28 : 916 921. (Pubitemid 27209133)
9. Kreuter MW, Strecher VJ. Changing inaccurate perceptions of health risk: results from a randomized trial. Health Psychology 1995 14 : 56 63.
10. Albers GW, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 1998 114 : S683 S698. (Pubitemid 28535789)
11. Rockson SG, Albers GW. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation. Journal of the American College of Cardiology 2004 43 : 929 935. (Pubitemid 38401065)
12. Rossnagel K, Jungehulsing GJ, Nolte CH, et al. Out-of-hospital delays in patients with acute stroke. Annals of Emergency Medicine 2004 44 : 476 483. (Pubitemid 39425049)
13. Nolte CH, Muller-Nordhorn J, Jungehulsing GJ, et al. Symptoms, risk factors, and etiology of transient ischemic attack and stroke. Nervenarzt 2005 76 : 1231 1238. (Pubitemid 41436247)
14. Muller-Nordhorn J, Nolte CH, Rossnagel K, et al. Medical management in patients following stroke and transitory ischemic attack: a comparison between men and women. Cerebrovascular Disease 2006 21 : 329 335. (Pubitemid 44617296)
15. Berger K, Weltermann B, Kolominsky-Rabas P, et al. The reliability of stroke scales. The german version of NIHSS, ESS and Rankin scales. Fortschritte der Neurologie-Psychiatrie 1999 67 : 81 93. (Pubitemid 29122509)
16. Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993 24 : 35 41. (Pubitemid 23014379)
17. Hillen T, Dundas R, Lawrence E, Stewart JA, Rudd AG, Wolfe CD. Antithrombotic and antihypertensive management 3 months after ischemic stroke: a prospective study in an inner city population. Stroke 2000 31 : 469 475. (Pubitemid 30078184)
18. Mouradian MS, Majumdar SR, Senthilselvan A, Khan K, Shuaib A. How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack? Stroke 2002 33 : 1656 1659. (Pubitemid 34619974)
19. Joseph LN, Babikian VL, Allen NC, Winter MR. Risk factor modification in stroke prevention: the experience of a stroke clinic. Stroke 1999 30 : 16 20. (Pubitemid 29029435)
20. Kothari R, Sauerbeck L, Jauch E, et al. Patients' awareness of stroke signs, symptoms, and risk factors. Stroke 1997 28 : 1871 1875. (Pubitemid 27458987)
21. Pancioli AM, Broderick J, Kothari R, et al. Public perception of stroke warning signs and knowledge of potential risk factors. JAMA 1998 279 : 1288 1292. (Pubitemid 28180782)
22. Muller-Nordhorn J, Nolte CH, Rossnagel K, et al. Knowledge about risk factors for stroke: a population-based survey with 28,090 participants. Stroke 2006 37 : 946 950.
23. Parahoo K, Thompson K, Cooper M, Stringer M, Ennis E, McCollam P. Stroke: awareness of the signs, symptoms and risk factors - a population-based survey. Cerebrovascular Disease 2003 16 : 134 140. (Pubitemid 36693844)
24. Sappok T, Faulstich A, Stuckert E, Kruck H, Marx P, Koennecke HC. Compliance with secondary prevention of ischemic stroke: a prospective evaluation. Stroke 2001 32 : 1884 1889. (Pubitemid 32772225)
25. Touzé E, Coste J, Voicu M, et al. Importance of in-hospital initiation of therapies and therapeutic inertia in secondary stroke prevention: IMplementation of Prevention After a Cerebrovascular evenT (IMPACT) Study. Stroke 2008 39 : 1834 1843.
26. Collins R, Armitage J, Parish S, Sleight P, Peto R. Heart Protection Study Collaborative Group effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004 363 : 757 767.
27. Briel M, Studer M, Glass TR, Bucher HC. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. American Journal of Medicine 2004 117 : 596 606. (Pubitemid 39304211)
28. Adams RJ, Albers G, Alberts MJ, et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 2008 39 : 1647 1652.
29. Deplanque D, Corea F, Arquizan C, et al. Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand? SAFE I Study Investigators. Heart 1999 82 : 563 569. (Pubitemid 29515449)
30. Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Carolei A. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 2005 36 : 1115 1119. (Pubitemid 40803473)
31. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 126 : 483S 512S. (Pubitemid 39297962)
32. Lummis HL, Sketris IS, Gubitz GJ, Joffres MR, Flowerdew GJ. Medication persistence rates and factors associated with persistence in patients following stroke: a cohort study. BMC Neurology 2008 8 : 25.
33. Daffertshofer M, Mielke O, Pullwitt A, Felsenstein M, Hennerici M. Transient ischemic attacks are more than "ministrokes". Stroke 2004 35 : 2453 2458. (Pubitemid 39458398)
34. Kolominsky-Rabas PL, Sarti C, Heuschmann PU, et al. A prospective community-based study of stroke in Germany - the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. Stroke 1998 29 : 2501 2506. (Pubitemid 28543997)